BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

Inhibiting an NMDA receptor to reduce lupus neurological symptoms

Claire Quang
April 30, 2020 6:06 PM UTC

INDICATION: Lupus...

BCIQ Company Profiles

Feinstein Institute for Medical Research

Stony Brook University

BCIQ Target Profiles

NMDA receptor NR2A subtype (GRIN2A) (NR2A)

BCIQ Company Profiles

Feinstein Institute for Medical Research

Stony Brook University

BCIQ Target Profiles

NMDA receptor NR2A subtype (GRIN2A) (NR2A)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS